ReviewCancer drug resistance (Alhambra, Calif.)2019

Mechanistic target of rapamycin inhibitors: successes and challenges as cancer therapeutics.

Muireann Ní Bhaoighill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.